Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Perspective Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CATX.
You can purchase shares of Perspective Therapeutics (AMEX:CATX) through any online brokerage.
Other companies in Perspective Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), 4D Molecular Therapeutics (NASDAQ:FDMT), Korro Bio (NASDAQ:KRRO) and Larimar Therapeutics (NASDAQ:LRMR).
Perspective Therapeutics has a consensus price target of $9.85.
The stock price for Perspective Therapeutics (AMEX: CATX) is $1.945 last updated April 22, 2025 at 11:39 AM EDT.
There are no upcoming dividends for Perspective Therapeutics.
Perspective Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.
There is no upcoming split for Perspective Therapeutics.
Perspective Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.